Biohaven Ltd.

BHVNNYSE • USD
13.98 USD
↗ 0.15 (1.12%)🟢PRE MARKET (AS OF 09:04 AM EST)
🟢Market: OPEN

Biohaven Ltd. (BHVN) trades at $13.98 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (552.4%) and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Nov 13, 2026.

Open?$13.82
High?$14.82
Low?$12.92
Prev. Close?$13.82
Volume?90.0K
Avg. Volume?3.2M
VWAP?$14.16
Rel. Volume?0.03x
Bid / Ask
Bid?$13.90 × 500
Ask?$14.19 × 200
Spread?$0.29
Midpoint?$14.05
Valuation & Ratios
Market Cap?2.1B
Shares Out?151.1M
Float?119.8M
Float %?79.3%
P/E Ratio?N/A
P/B Ratio?-21.25
EPS?-$3.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
Employees
274
Market Cap
2.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2022-09-23
Address
215 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-404-0410
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
65
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?-15.69Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?12.54%High
Short Interest?15.0M
Days to Cover?2.9
Free Float119.8M
Avg Daily Volume5.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.05Strong
Quick Ratio?3.05Strong
Cash Ratio?1.53Strong
Debt/Equity?-2.69Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-21.25CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-4.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
552.4%STRONG▾
ROA?
S&P
3
-205.8%WEAK▾
Cash Flow & Enterprise
FCF?$-473172000
Enterprise Value?$2.3B
Fundamentals ratios updated end of day